QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics

Go back to QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics

Qiagen NV (QGEN) PT Raised to $43 at Deutsche Bank

August 3, 2018 8:50 AM EDT

Deutsche Bank raised its price target on Qiagen NV (NYSE: QGEN) to $43.00 (from $42.00) while maintaining a Buy rating.

Analyst Gunnar Romer commented, "Qiagen reported strong 2Q earnings, above its own guidance and Street expectations. 2Q sales were up 6% CER (5-6%... More

Qiagen NV (QGEN) PT Raised to $39.50 at Evercore ISI

August 1, 2018 12:13 PM EDT

Evercore ISI analyst Ross Muken raised the price target on Qiagen NV (NYSE: QGEN) to $39.50 (from $38.00) while maintaining an Outperform rating following results.

... More